Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irum Khan

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Blood Cancer Journal|March 7, 2024
Regulation of HOX gene expression in AMLIrum Khan, Mohammed A Amin, Elizabeth A Eklund, et al.
Frontiers in Oncology|August 12, 2021
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AMLMikhail S Chesnokov, Soheila Borhani, Marianna Halasi, et al.
Oncology (Williston Park, N.Y.)|July 31, 2010
Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic optionsChristiane Querfeld, Irum Khan, Brett Mahon, et al.
Peerj|June 29, 2026
Trait prioritization and genotype selection for heat stress tolerance in wheat <i>via</i> structural equation modeling and principal component analysis (PCA)Irum Khan, Muhammad Kashif Naeem, Mehraj Abbasov, et al.
Blood|June 22, 2006
c-Myc mediates pre-TCR-induced proliferation but not developmental progressionMarei Dose, Irum Khan, Zhuyan Guo, et al.
Cancer Causes & Control : CCC|April 10, 2021
Impact of race on outcomes in intermediate-risk acute myeloid leukemiaIvy Elizabeth Abraham, Anand Ashwin Patel, Heidy Wang, et al.
Trauma, Violence & Abuse|September 26, 2024
Association of Childhood Sexual Abuse with Adolescent's Psychopathology: A Systematic Review and Meta-AnalysisMohammad Hashim, Naved Iqbal, Sarah Halligan, et al.
Cell Death Discovery|May 2, 2024
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapiesSanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Iranian Journal of Pharmaceutical Research : IJPR|December 14, 2021
Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization, <i>In-vitro</i> and <i>In-vivo</i> EvaluationFahim Ullah Khan, Fazli Nasir, Zafar Iqbal, et al.
Cell Death & Disease|January 26, 2018
Honokiol is a FOXM1 antagonistMarianna Halasi, Ben Hitchinson, Binal N Shah, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Blood Cancer Journal|March 7, 2024
Regulation of HOX gene expression in AMLIrum Khan, Mohammed A Amin, Elizabeth A Eklund, et al.
Frontiers in Oncology|August 12, 2021
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AMLMikhail S Chesnokov, Soheila Borhani, Marianna Halasi, et al.
Oncology (Williston Park, N.Y.)|July 31, 2010
Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic optionsChristiane Querfeld, Irum Khan, Brett Mahon, et al.
Peerj|June 29, 2026
Trait prioritization and genotype selection for heat stress tolerance in wheat <i>via</i> structural equation modeling and principal component analysis (PCA)Irum Khan, Muhammad Kashif Naeem, Mehraj Abbasov, et al.
Blood|June 22, 2006
c-Myc mediates pre-TCR-induced proliferation but not developmental progressionMarei Dose, Irum Khan, Zhuyan Guo, et al.
Cancer Causes & Control : CCC|April 10, 2021
Impact of race on outcomes in intermediate-risk acute myeloid leukemiaIvy Elizabeth Abraham, Anand Ashwin Patel, Heidy Wang, et al.
Trauma, Violence & Abuse|September 26, 2024
Association of Childhood Sexual Abuse with Adolescent's Psychopathology: A Systematic Review and Meta-AnalysisMohammad Hashim, Naved Iqbal, Sarah Halligan, et al.
Cell Death Discovery|May 2, 2024
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapiesSanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Iranian Journal of Pharmaceutical Research : IJPR|December 14, 2021
Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization, <i>In-vitro</i> and <i>In-vivo</i> EvaluationFahim Ullah Khan, Fazli Nasir, Zafar Iqbal, et al.
Cell Death & Disease|January 26, 2018
Honokiol is a FOXM1 antagonistMarianna Halasi, Ben Hitchinson, Binal N Shah, et al.
Pageof 5